Molecular cytogenetic study of derivative chromosome 9 deletion in chronic myeloid leukemia patients

Bennour, Ayda; Ouahchi, Ines; Ben Youssef, Yosra; Zaier, Monia; Laatiri, Mohamed; Harrabi, Imed; Meddeb, Balkis; Elloumi, Moez; Khelif, Abderrahim; Saad, Ali; Sennana, Halima
June 2012
Medical Oncology;Jun2012, Vol. 29 Issue 2, p1151
Academic Journal
The aims of this study are to investigate the frequency of derivative chromosome 9 (der (9)) deletion in Tunisian patients with chronic myeloid leukemia (CML) and to assess the correlation between this deletion and the cytogenetic response for patients treated with hydroxyurea (HU) or imatinib (IM). Karyotype analysis of 336 patients with CML was performed with R-banding technique. Fluorescence in situ hybridization (FISH) was carried using home-brew probes 17L7 and 248J22 for detecting, respectively, adjacent 5′ ABL and 3′ BCR deletions on der(9). Cytogenetic study demonstrated typical t(9;22)(q34;q11) translocation in 89.6% and variant translocation in 10.4% of patients. Interphase FISH studies showed deletion of der(9) in 59 (17.6%) of the 336 patients, 23 (39%) of them had variant rearrangements. There are 19 patients with solely 5′ ABL deletion and 40 with concomitant 5′ ABL and 3′ BCR deletions. Cytogenetic response was evaluated during 18 months with HU or IM therapy. Our results demonstrate that (a) 3′ BCR deletion is associated with 5′ ABL deletion in all patients with der(9) deletions, (b) the 5′ ABL and 3′ BCR deletions arise simultaneously with t(9;22), (c) deletions on der(9) chromosome were frequently encountered in older patients and in patients presenting variant rearrangements, (d) both 5′ ABL and 3′ BCR deletions were associated with cytogenetic response failure in patients treated with HU, however, patients treated with IM and carrying der(9) deletions presented better cytogenetic response.


Related Articles

  • E355G mutation appearing in a patient with e19a2 chronic myeloid leukaemia resistant to imatinib. Bennour, Ayda; Beaufils, Nathalie; Sennana, Halima; Meddeb, Balkis; Saad, Ali; Gabert, Jean // Journal of Clinical Pathology;Aug2010, Vol. 63 Issue 8, p737 

    The development of imatinib is a milestone in the treatment of chronic myeloid leukaemia (CML), and its therapeutic effect has been extensively investigated in patients with CML who carry M-bcr and m-bcr BCR–ABL fusion transcripts. However, knowledge about its therapeutic effect on...

  • Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. Vandenberghe, P.; Wlodarska, I.; Michaux, L.; Zachée, P.; Boogaerts, M.; Vanstraelen, D.; Herregods, M-C; van Hoof, A.; SelIeslag, D.; Roufosse, F.; Maerevoet, M.; Verhoef, G.; Cools, J.; Gilliland, DG; Hagemeijer, A.; Marynen, P.; Zachée, P; Selleslag, D; Gilliland, D G // Leukemia (08876924);Apr2004, Vol. 18 Issue 4, p734 

    Detection of the FIP1L1-PDGFRA fusion gene or the corresponding cryptic 4q12 deletion supports the diagnosis of chronic eosinophilic leukemia (CEL) in patients with chronic hypereosinophilia. We retrospectively characterized 17 patients fulfilling WHO criteria for idiopathic hypereosinophilic...

  • Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases. Kraehn, G M; Utikal, J; Udart, M; Greulich, K M; Bezold, G; Kaskel, P; Leiter, U; Peter, R U // British Journal of Cancer;1/1/2001, Vol. 84 Issue 1, p72 

    Amplification and overexpression of the c-myc gene have been associated with neoplastic transformation in a plethora of malignant tumours. We applied interphase fluorescence in situ hybridization (FISH) with a locus-specific probe for the c-myc gene (8q24) in combination with a corresponding...

  • Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients. Godon, A; Moreau, A; Talmant, P; Baranger-Papot, L; Geneviève, F; Milpied, N; Zandecki, M; Avet-Loiseau, H // Leukemia (08876924);Jan2003, Vol. 17 Issue 1, p255 

    The translocation (14;18)(q32;q21) is the hallmark of follicular lymphoma (FL). However, conventional cytogenetics and PCR techniques fail to detect it in at least 10% of cases. In order to evaluate the true incidence of this translocation in FL, we analyzed 63 patients with FL, and 17 patients...

  • Molecular cytogenetics: karyotype evolution, phylogenomics and future prospects. Robinson, T J; Yang, F // Heredity;Jan2012, Vol. 108 Issue 1, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including one related to chromosomal rearrangements and genomic structural variation, cross-species fluorescence in situ hybridization (FISH) and genome analysis of chromosomal breakage.

  • FISH in Pathology. Coyne, John D. // International Journal of Surgical Pathology;Aug2012, Vol. 20 Issue 4, p377 

    The article focuses on the use of FISH (fluorescence in situ hybridization) in pathology.

  • Automated lab assistant provides on-board hybridization.  // Urology Times;Feb2012, Vol. 40 Issue 2, p48 

    The article offers brief information on the ThermoBrite Elite hybridization system from Iris Sample Processing.

  • ERRATUM.  // Neurology India;Mar/Apr2014, Vol. 62 Issue 2, p191 

    A correction to the article "Fluorescence in situ Hybridization for 1p 19q Status in a Cohort of Glial Neoplasms," that appeared in the Junary 2014 issue is presented.

  • FISH for the Detection of 1p and 19q Deletions in Oligodendrogioma Paraffin Wax Sections - A Retrospective Study of 55 Cases.  // Journal of Medical Genetics;Sep2006 Supplement, Vol. 43, pS101 

    An abstract of the article "FISH for the Detection of 1p and 19q Deletions in Oligodendrogioma Paraffin Wax Sections - A Retrospective Study of 55 Cases," by Neil Atkey, S. B. Wharton, D. Jellinek, and E. L. Maltby is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics